CD117 immunoreactivity in atypical fibroxanthoma

American Journal of Dermatopathology

Volumn 31, Issue 1, 2009, Pages 96-98

  Barr, Keira L ^a   Russo, Jacqueline J ^a   Vincek, Vladimir ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

DATA BASE; FIBROXANTHOMA; HUMAN; IMMUNOREACTIVITY; LETTER; PRIORITY JOURNAL; AGED; BIOSYNTHESIS; DERMATOFIBROMA; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; NOTE; PATHOLOGY; SKIN TUMOR;

AGED; AGED, 80 AND OVER; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 62349085641     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181853862     Document Type: Letter

References (5)

1. Mathew RA, Schlauder SM, Calder KB, et al. CD117 immunoreactivity in atypical fibroxan-thoma. Am J Dermatopathol. 2008;30: 34-36.
2. Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13:205-220. Review.
3. Hornick JL, Fletcher CDM. Validating immu-nohistochemical staining for KIT (CD117). Am J Clin Pathol. 2003;119:325-327.
4. Lucas DR, Al-Abbadi M, Tabaczka P, et al. c-Kit expression in desmoid fibromatosis: comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol. 2003; 119:339-345.
5. Hornick JL, Fletcher CDM. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol. 2002;117:188-193.